日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

驱动基因组合决定皮肤鳞状细胞癌疾病的连续进展。

Peter Bailey ,Rachel A Ridgway ,Patrizia Cammareri ,Mairi Treanor-Taylor ,Ulla-Maja Bailey ,Christina Schoenherr ,Max Bone ,Daniel Schreyer ,Karin Purdie ,Jason Thomson ,William Rickaby ,Rene Jackstadt ,Andrew D Campbell ,Emmanouil Dimonitsas ,Alexander J Stratigos ,Sarah T Arron ,Jun Wang ,Karen Blyth ,Charlotte M Proby ,Catherine A Harwood ,Owen J Sansom ,Irene M Leigh ,Gareth J Inman

Mena regulates nesprin-2 to control actin-nuclear lamina associations, trans-nuclear membrane signalling and gene expression

Mena通过调节nesprin-2来控制肌动蛋白-核纤层结合、跨核膜信号传导和基因表达。

Frederic Li Mow Chee ,Bruno Beernaert ,Billie G C Griffith ,Alexander E P Loftus ,Yatendra Kumar ,Jimi C Wills ,Martin Lee ,Jessica Valli ,Ann P Wheeler ,J Douglas Armstrong ,Maddy Parsons ,Irene M Leigh ,Charlotte M Proby ,Alex von Kriegsheim ,Wendy A Bickmore ,Margaret C Frame ,Adam Byron

Multimodal Transplant-clinic-based Skin Cancer Prevention Education for Organ Transplant Recipients: Feasibility Study

基于移植诊所的多模式皮肤癌预防教育在器官移植受者中的应用:可行性研究

Yu, Regina; Miura, Kyoko; Chambers, Daniel C; Hopkins, Peter M; Proby, Charlotte M; Bibee, Kristin; Plasmeijer, Elsemieke I; Green, Adele C

Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma

在小鼠皮肤鳞状细胞癌模型中检测到临床相关的异常 Filip1l DNA 甲基化

Kevin Roth, Louis Coussement, Elena V Knatko, Maureen Higgins, Sandra Steyaert, Charlotte M Proby, Tim de Meyer, Albena T Dinkova-Kostova

The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020

2020年新冠疫情对英格兰皮肤癌发病率和治疗的影响

Venables, Z C; Ahmed, S; O Bleiker, T; Broggio, J; Kwiatkowska, M; Levell, N J; Millington, G W M; Paley, L; Payne, E; M Proby, C; Vernon, S; McPhail, S

Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells

磺酰硫代氨基甲酸酯 S-4 抑制人类皮肤鳞状细胞癌细胞中的 HSP90

Ying Zhang, Garrett C VanHecke, Young-Hoon Ahn, Charlotte M Proby, Albena T Dinkova-Kostova

Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model

研究使用组蛋白去乙酰化酶抑制剂 MS-275 作为外用药物预防和治疗 SKH-1 无毛小鼠模型中的皮肤鳞状细胞癌

Jay H Kalin, Abdulkerim Eroglu, Hua Liu, W David Holtzclaw, Irene Leigh, Charlotte M Proby, Jed W Fahey, Philip A Cole, Albena T Dinkova-Kostova

Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis

揭示衰老真皮成纤维细胞与皮肤鳞状细胞癌细胞系在肿瘤发生不同阶段的相互作用

Marie Toutfaire, Elise Dumortier, Antoine Fattaccioli, Martine Van Steenbrugge, Charlotte M Proby, Florence Debacq-Chainiaux

Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity

针对剪接体进行皮肤鳞状细胞癌治疗:c-MYC 和野生型 p53 在确定肿瘤选择性程度中的作用

Lydia A Hepburn, Angela McHugh, Kenneth Fernandes, Garry Boag, Charlotte M Proby, Irene M Leigh, Mark K Saville

Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity

蛋白酶体和泛素 E1 酶抑制剂在皮肤鳞状细胞癌中的临床前比较:差异敏感性机制的识别

Angela McHugh, Kenneth Fernandes, Andrew P South, Jemima E Mellerio, Julio C Salas-Alanís, Charlotte M Proby, Irene M Leigh, Mark K Saville